1. Rogers DF (2007): Physiology of airway mucus secretion and pathophysiology of hypersecretion. Respir Care 52: 1134-1146.
2.
Saco TV, Breitzig MT, Lockey RF, et al. (2018): Epigenetics of mucus hypersecretion in chronic respiratory diseases. Am J Respir Cell Mol Biol 58: 299-309.
3.
Jaramillo AM, Vladar EK, Holguin F, et al. (2024): Emerging cell and molecular targets for treating mucus hypersecretion in asthma. Allergol Int 73: 375-381.
4.
Hill DB, Button B, Rubinstein M, et al. (2022): Physiology and pathophysiology of human airway mucus. Physiol Rev 102: 1757-1836.
5.
Svitkina TM (2020): Actin cell cortex: structure and molecular organization. Trends Cell Biol 30: 556-565.
6.
Chugh P, Paluch EK (2018): The actin cortex at a glance. J Cell Sci 131: 186254.
7.
Bandela M, Belvitch P, Garcia JGN, et al. (2022): Cortactin in lung cell function and disease. Int J Mol Sci 23: 4606.
8.
Belvitch P, Htwe YM, Brown ME, et al. (2018): Cortical actin dynamics in endothelial permeability. Curr Top Membr 82: 141-195.
9.
Ponce AG, Madrid AFC, Robles HV, et al. (2016): Loss of cortactin causes endothelial barrier dysfunction via disturbed adrenomedullin secretion and actomyosin contractility. Sci Rep 6: 29003.
10.
Liu C, Li Q, Zhou X, et al. (2013): Cortactin mediates elevated shear stress-induced mucin hypersecretion via actin polymerization in human airway epithelial cells. Int J Biochem Cell Biol 45: 2756-2763.
11.
Voynow JA, Shinbashi M (2021): Neutrophil elastase and chronic lung disease. Biomolecules 11: 1065.
12.
Gornowicz-Porowska J, Bowszyc-Dmochowska M, Seraszek-Jaros A, et al. (2014): Cutaneous expressions of interleukin-6 and neutrophil elastase as well as levels of serum IgA antibodies to gliadin nonapeptides, tissue transglutaminase and epidermal transglutaminase: implications for both autoimmunity and autoinflammation involvement in dermatitis herpetiformis. Cent Eur J Immunol 39: 331-337.
13.
Flores CFY, de Las Mercedes Hurtado Pineda Á, Bonilla VMC, et al. (2020): Sample management: stability of plasma and serum on different storage conditions. Ejifcc 31: 46-55.
14.
Sheats MK, Yin Q, Fang S, et al. (2019): Marcks and lung disease. Am J Respir Cell Mol Biol 60: 16-27.
15.
Eckert RE, Neuder LE, Park J, et al. (2010): Myristoylated alanine-rich c-kinase substrate (marcks) protein regulation of human neutrophil migration. Am J Respir Cell Mol Biol 42: 586-594.
16.
Estrada-Bernal A, Gatlin JC, Sunpaweravong S, et al. (2009): Dynamic adhesions and marcks in melanoma cells. J Cell Sci 122: 2300-2310.
17.
Salli U, Saito N, Stormshak F (2003): Spatiotemporal interactions of myristoylated alanine-rich c kinase substrate (marcks) protein with the actin cytoskeleton and exocytosis of oxytocin upon prostaglandin f2alpha stimulation of bovine luteal cells. Biol Reprod 69: 2053-2058.
18.
Chen P, Deng Z, Wang T, et al. (2013): The potential interaction of marcks-related peptide and diltiazem on acrolein-induced airway mucus hypersecretion in rats. Int Immunopharmacol 17: 625-632.
19.
Agrawal A, Rengarajan S, Adler KB, et al. (2007): Inhibition of mucin secretion with marcks-related peptide improves airway obstruction in a mouse model of asthma. J Appl Physiol (1985) 102: 399-405.
20.
Modzelewska K, Newman LP, Desai R, et al. (2006): Ack1 mediates cdc42-dependent cell migration and signaling to p130cas. J Biol Chem 281: 37527-37535.
21.
Lin Q, Lo CG, Cerione RA, et al. (2002): The cdc42 target ack2 interacts with sorting nexin 9 (sh3px1) to regulate epidermal growth factor receptor degradation. J Biol Chem 277: 10134-10138.
22.
He L, Lin Y, Ge Z, et al. (2019): The legionella pneumophila effector wipa disrupts host f-actin polymerisation by hijacking phosphotyrosine signalling. Cell Microbiol 21: e13014.
23.
Lažetić V, Joseph BB, Bernazzani SM, et al. (2018): Actin organization and endocytic trafficking are controlled by a network linking nima-related kinases to the cdc-42-sid-3/ack1 pathway. PLoS Genet 14: e1007313.
24.
Posch W, Lass-Flörl C, Wilflingseder D (2021): SARS-cov-2-infected primary human airway epithelia illustrate mucus hypersecretion. J Allergy Clin Immunol 148: 909.
25.
Prasher P, Sharma M (2022): Targeting mucin hypersecretion in covid-19 therapy. Future Med Chem 14: 681-684.
26.
Singanayagam A, Footitt J, Marczynski M, et al. (2022): Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease. J Clin Invest 132: e120901.
27.
Jaramillo AM, Azzegagh Z, Tuvim MJ, et al. (2018): Airway mucin secretion. Ann Am Thorac Soc 15: S164-S170.
28.
Adler KB, Tuvim MJ, Dickey BF (2013): Regulated mucin secretion from airway epithelial cells. Front Endocrinol (Lausanne) 4: 129.
29.
Jin BY, Lin AJ, Golan DE, et al. (2012): Marcks protein mediates hydrogen peroxide regulation of endothelial permeability. Proc Natl Acad Sci U S A 109: 14864-14869.
30.
Lin K, Fang S, Park J, et al. (2010): Marcks and related chaperones bind to unconventional myosin v isoforms in airway epithelial cells. Am J Respir Cell Mol Biol 43: 131-136.
31.
Polosukhin VV, Cates JM, Lawson WE, et al. (2011): Hypoxia-inducible factor-1 signalling promotes goblet cell hyperplasia in airway epithelium. J Pathol 224: 203-211.
32.
Green TD, Crews AL, Park J, et al. (2011): Regulation of mucin secretion and inflammation in asthma: a role for marcks protein. Biochim Biophys Acta 1810: 1110-1113.
33.
Park J, Crews AL, Lampe WR, et al. (2007): Protein kinase c delta regulates airway mucin secretion via phosphorylation of marcks protein. Am J Pathol 171: 1822-1830.
34.
Jeannot P, Besson A (2020): Cortactin function in invadopodia. Small Gtpases 11: 256-270.
35.
González-Jamett AM, Guerra MJ, Olivares MJ, et al. (2017): The f-actin binding protein cortactin regulates the dynamics of the exocytotic fusion pore through its sh3 domain. Front Cell Neurosci 11: 130.
36.
Schnoor M, Stradal TE, Rottner K (2018): Cortactin: cell functions of a multifaceted actin-binding protein. Trends Cell Biol 28: 79-98.
37.
Wang R, Cleary RA, Wang T, et al. (2014): The association of cortactin with profilin-1 is critical for smooth muscle contraction. J Biol Chem 289: 14157-14169.
38.
Brescia G, Parrino D, Nicolè L, et al. (2018): Cortactin expression in nasal polyps of aspirin-exacerbated respiratory disease (AERD) patients. Am J Otolaryngol 39: 293-298.
39.
Cleary RA, Wang R, Waqar O, et al. (2014): Role of c-abl tyrosine kinase in smooth muscle cell migration. Am J Physiol Cell Physiol 306: C753-C761.
40.
Rizzo AN, Aman J, van Nieuw Amerongen GP, et al. (2015): Targeting abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome. Arterioscler Thromb Vasc Biol 35: 1071-1079.
41.
Yu D, Makkar G, Strickland DK, et al. (2015): Myristoylated alanine-rich protein kinase substrate (MARCKS) regulates small GTPase rac1 and cdc42 activity and is a critical mediator of vascular smooth muscle cell migration in intimal hyperplasia formation. J Am Heart Assoc 4: e002255.
42.
Mahajan K, Mahajan NP (2015): Ack1/tnk2 tyrosine kinase: molecular signaling and evolving role in cancers. Oncogene 34: 4162-4167.
43.
Jing L, Zhang X, Liu D, et al. (2022): ACK1 contributes to the pathogenesis of inflammation and autoimmunity by promoting the activation of TLR signaling pathways. Front Immunol 13: 864995.
